Midi Health vs HealthRX

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Midi Health vs HealthRX: Overview

Choosing between Midi Health and HealthRX for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Midi Health offers both semaglutide and tirzepatide at $164/month with a rating of 8.6/10. HealthRX also provides both semaglutide and tirzepatide at $133/month with a 8.5/10 rating.

With only a $31/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$31/mo
Rating Difference
0.1
Winner
Midi Health
Best For
Quality

Midi Health

View full Midi Health review →
Rating
8.6/10Better
Monthly Price
$164
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

  • The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
  • Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
  • Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
  • Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
  • There is no membership fee. You pay for care and medication only
  • Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
  • Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
  • The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
  • Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
  • Available in all 50 states

Cons

  • The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
  • Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
  • Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
  • Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
  • Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
  • Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
  • The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Choose Midi Health

HealthRX

View full HealthRX review →
Rating
8.5/10
Monthly Price
$133Cheaper
Medications
semaglutidetirzepatide

Pros

  • Efficacy claims are cited to the actual trials with duration and source: 'Average 15% body-weight loss at 68 weeks in STEP-1' for semaglutide and 'Average 21% body-weight loss at 72 weeks in pivotal phase-3 trial' for tirzepatide, referencing NEJM 2021, each followed immediately by 'Not FDA-approved'
  • The competitor price comparison is dated and sourced - 'published monthly prices at comparable telehealth clinics, July 2026' and 'Prices as displayed on each clinic's public site' - rather than an unattributed claim of being cheapest
  • LegitScript certification is given with its certificate number (50087439), so it can be independently verified
  • Pricing is low and clearly tiered: compounded semaglutide from $133/mo on a 3-month plan or $99/mo on 12 months, and tirzepatide from $209/mo or $179/mo on 12 months (checked July 27, 2026)
  • Same price at every dose, so titration does not raise the bill
  • Full refund if a licensed provider does not approve you, and the site states outright that paying does not guarantee a prescription
  • Cancel anytime 'in one click', with free overnight cold-chain shipping and availability in all 50 states
  • The 503A regulatory category is named specifically rather than the vaguer 'FDA-registered facility' language competitors prefer

Cons

  • The '4.8 · 12,000+ members' rating shown in the header has no traceable source - we found no Trustpilot profile for the domain and no other public review platform carrying it
  • The advertised prices are plan prices, not month-to-month rates. '$133/mo' is the 3-month plan and '$99/mo' requires committing to a full year; no single-month price is displayed
  • Committing 12 months upfront to a compounded medication means paying for a year before you know how you tolerate it
  • No BBB profile or independent complaint record exists to check the service against
  • No published customer phone number or support hours
  • The competitor comparison, while dated and sourced, is still marketing produced by the company that benefits from it
  • As with every compounded GLP-1, the trial figures quoted come from the branded medicines rather than the compounded product actually dispensed - HealthRX says so, but the numbers still headline the page
Choose HealthRX

Feature-by-feature comparison

FeatureMidi HealthHealthRX
Monthly Price$164$133
Rating8.6/108.5/10
Medicationscompounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1ssemaglutide, tirzepatide
Insurance AcceptedYesNo
Support HoursNot publishedNot published
Live ChatNoNo
Free ShippingYesYes
Shipping SpeedDiscreet shipping included in every quoted medication priceFree overnight shipping, ships cold in 24-48 hours
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyContinued care visits with the same clinician, covered by insurance for qualifying patientsProvider review and ongoing support included
Money-back GuaranteeNone publishedFull refund if a licensed provider does not approve you for treatment
Cancellation PolicyNo membership fee and no subscription lock-in; you pay for care and medication onlyCancel anytime in one click; plan prices are paid upfront for the term selected

Which should you choose?

Choose Midi Health if you:

  • Prefer a higher-rated service (8.6/10 vs 8.5/10)
  • Want more medication options to choose from
  • Need insurance coverage for your treatment
  • Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Choose HealthRX if you:

  • Want to save $31/month with a more affordable option
  • Value: efficacy claims are cited to the actual trials with duration and source: 'average 15% body-weight loss at 68 weeks in step-1' for semaglutide and 'average 21% body-weight loss at 72 weeks in pivotal phase-3 trial' for tirzepatide, referencing nejm 2021, each followed immediately by 'not fda-approved'

Website previews

Midi Health

Midi Health website

HealthRX

HealthRX website

Our recommendation

Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Midi Health

Compare other providers

Compare GLP-1 Brands